FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing

FASEB Journal

Volumn 32, Issue 1, 2018, Pages 289-303

  Ang, Zhiwei ^a   Xiong, Ding ^a,b   Wu, Min ^a,b,c   Ding, Jeak Ling ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

FFA2 GPR43; FFA3 GPR41; GPCR heteromer

Indexed keywords

BETA ARRESTIN 2; CALCIUM ION; FREE FATTY ACID RECEPTOR 2; FREE FATTY ACID RECEPTOR 3; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PURINERGIC P2Y RECEPTOR; SHORT CHAIN FATTY ACID; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; ARRB2 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; CYCLIC AMP; FFAR3 PROTEIN, HUMAN; G-PROTEIN COUPLED RECEPTOR 43, HUMAN; RECOMBINANT PROTEIN; VOLATILE FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEACHING; CALCIUM SIGNALING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELL LINE; HEK293T CELL LINE; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INTRACELLULAR SIGNALING; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STABLE EXPRESSION; BIOSYNTHESIS; CHEMISTRY; COLITIS; GENETICS; METABOLISM; OBESITY; PHOSPHORYLATION; PROTEIN MULTIMERIZATION;

BETA-ARRESTIN 2; CALCIUM SIGNALING; COLITIS; CYCLIC AMP; FATTY ACIDS, VOLATILE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELLS; HUMANS; MACROPHAGES; OBESITY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT PROTEINS;

EID: 85040180462     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201700252RR     Document Type: Article

References (58)

1. Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., Pike, N. B., Strum, J. C., Steplewski, K. M., Murdock, P. R., Holder, J. C., Marshall, F. H., Szekeres, P. G., Wilson, S., Ignar, D. M., Foord, S. M., Wise, A., and Dowell, S. J. (2003) The Orphan G protein–coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312–11319
2. Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., Parmentier, M., and Detheux, M. (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278, 25481–25489
3. Tang, C., Ahmed, K., Gille, A., Lu, S., Gröne, H.-J., Tunaru, S., and Offermanns, S. (2015) Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. Nat. Med. 21, 173–177
4. Ge, H., Li, X., Weiszmann, J., Wang, P., Baribault, H., Chen, J.-L., Tian, H., and Li, Y. (2008) Activation of G protein–coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 149, 4519–4526
5. Bjursell, M., Admyre, T., Göransson, M., Marley, A. E., Smith, D. M., Oscarsson, J., and Bohlooly-Y, M. (2011) Improved glucose control and reduced body fat mass in free fatty acid receptor 2–deficient mice fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 300, E211–E220
6. Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., and Gribble, F. M. (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61, 364–371
7. Kimura, I., Ozawa, K., Inoue, D., Imamura, T., Kimura, K., Maeda, T., Terasawa, K., Kashihara, D., Hirano, K., Tani, T., Takahashi, T., Miyauchi, S., Shioi, G., Inoue, H., and Tsujimoto, G. (2013) The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4, 1829
8. McNelis, J. C., Lee, Y. S., Mayoral, R., van der Kant, R., Johnson, A. M. F., Wollam, J., and Olefsky, J. M. (2015) GPR43 potentiates beta cell function in obesity. Diabetes 64, 3203–3217
9. Priyadarshini, M., Villa, S. R., Fuller, M., Wicksteed, B., Mackay, C. R., Alquier, T., Poitout, V., Mancebo, H., Mirmira, R. G., Gilchrist, A., and Layden, B. T. (2015) An acetate-specific GPCR, FFAR2, regulates insulin secretion. Mol. Endocrinol. 29, 1055–1066
10. Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., Xavier, R. J., Teixeira, M. M., and Mackay, C. R. (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282–1286
11. Sina, C., Gavrilova, O., Förster, M., Till, A., Derer, S., Hildebrand, F., Raabe, B., Chalaris, A., Scheller, J., Rehmann, A., Franke, A., Ott, S., Häsler, R., Nikolaus, S., Fölsch, U. R., Rose-John, S., Jiang, H.-P., Li, J., Schreiber, S., and Rosenstiel, P. (2009) G protein–coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J. Immunol. 183, 7514–7522
12. Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., and Garrett, W. S. (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569–573
13. Masui, R., Sasaki, M., Funaki, Y., Ogasawara, N., Mizuno, M., Iida, A., Izawa, S., Kondo, Y., Ito, Y., Tamura, Y., Yanamoto, K., Noda, H., Tanabe, A., Okaniwa, N., Yamaguchi, Y., Iwamoto, T., and Kasugai, K. (2013) G protein–coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells. Inflamm. Bowel Dis. 19, 2848–2856
14. Kim, M. H., Kang, S. G., Park, J. H., Yanagisawa, M., and Kim, C. H. (2013) Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastro-enterology 145, 396–406.e1–e10
15. Macia, L., Tan, J., Vieira, A. T., Leach, K., Stanley, D., Luong, S., Maruya, M., Ian McKenzie, C., Hijikata, A., Wong, C., Binge, L., Thorburn, A. N., Chevalier, N., Ang, C., Marino, E., Robert, R., Offermanns, S., Teixeira, M. M., Moore, R. J., Flavell, R. A., Fagarasan, S., and Mackay, C. R. (2015) Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre–induced gut homeostasis through regulation of the inflammasome. Nat. Commun. 6, 6734
16. Vieira, A. T., Macia, L., Galvão, I., Martins, F. S., Canesso, M. C. C., Amaral, F. A., Garcia, C. C., Maslowski, K. M., De Leon, E., Shim, D., Nicoli, J. R., Harper, J. L., Teixeira, M. M., and Mackay, C. R. (2015) A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout. Arthritis Rheumatol. 67, 1646–1656
17. Sivaprakasam, S., Gurav, A., Paschall, A. V., Coe, G. L., Chaudhary, K., Cai, Y., Kolhe, R., Martin, P., Browning, D., Huang, L., Shi, H., Sifuentes, H., Vijay-Kumar, M., Thompson, S. A., Munn, D. H., Mellor, A., McGaha, T. L., Shiao, P., Cutler, C. W., Liu, K., Ganapathy, V., Li, H., and Singh, N. (2016) An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis. Oncogenesis 5, e238
18. Natarajan, N., Hori, D., Flavahan, S., Steppan, J., Flavahan, N. A., Berkowitz, D. E., and Pluznick, J. L. (2016) Microbial short chain fatty acid metabolites lower blood pressure via endothelial G-protein coupled receptor 41. Physiol. Genomics 48, 826–834
19. Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., and Marsland, B. J. (2014) Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20, 159–166
20. Sergeev, E., Hansen, A. H., Pandey, S. K., MacKenzie, A. E., Hudson, B. D., Ulven, T., and Milligan, G. (2016) Non-equivalence of key positively charged residues of the free fatty acid 2 receptor in the recognition and function of agonist versus antagonist ligands. J. Biol. Chem. 291, 303–317
21. Ng, J., Rashid, A. J., So, C. H., O’Dowd, B. F., and George, S. R. (2010) Activation of calcium/calmodulin-dependent protein kinase IIalpha in the striatum by the heteromeric D1-D2 dopamine receptor complex. Neuroscience 165, 535–541
22. Rodríguez-Ruiz, M., Moreno, E., Moreno-Delgado, D., Navarro, G., Mallol, J., Cortés, A., Lluís, C., Canela, E. I., Casadó, V., McCormick, P. J., and Franco, R. (2016) Heteroreceptor complexes formed by dopamine D1, histamine H3, and N-methyl-D-aspartate glutamate receptors as targets to prevent neuronal death in Alzheimer’s disease. Mol. Neurobiol. 54, 4537–4550
23. Rozenfeld, R., and Devi, L. A. (2007) Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. FASEB J. 21, 2455–2465
24. 1(A) receptor explored utilizing homo-FRET in live cells. Biophys. J. 100, 361–368
25. Armando, S., Quoyer, J., Lukashova, V., Maiga, A., Percherancier, Y., Heveker, N., Pin, J.-P., Prézeau, L., and Bouvier, M. (2014) The chemokine CXC4 and CC2 receptors form homo- and heterooligomers that can engage their signaling G-protein effectors and barrestin. FASEB J. 28, 4509–4523
26. Pei, L., Li, S., Wang, M., Diwan, M., Anisman, H., Fletcher, P. J., Nobrega, J. N., and Liu, F. (2010) Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects. Nat. Med. 16, 1393–1395
27. Karaki, S., Tazoe, H., Hayashi, H., Kashiwabara, H., Tooyama, K., Suzuki, Y., and Kuwahara, A. (2008) Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J. Mol. Histol. 39, 135–142
28. Tazoe, H., Otomo, Y., Karaki, S., Kato, I., Fukami, Y., Terasaki, M., and Kuwahara, A. (2009) Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed. Res. 30, 149–156
29. Ang, Z., Er, J. Z., Tan, N. S., Lu, J., Liou, Y.-C., Grosse, J., and Ding, J. L. (2016) Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonists. Sci. Rep. 6, 34145
30. Brantis, C. E., Ooms, F., Bernard, J. (2011) Novel amino acid derivatives and their use as GPR43 receptor modulators. Patent WO/2011/ 092284
31. Park, B.-O., Kim, S. H., Kong, G. Y., Kim, D. H., Kwon, M. S., Lee, S. U., Kim, M.-O., Cho, S., Lee, S., Lee, H.-J., Han, S.-B., Kwak, Y. S., Lee, S. B., and Kim, S. (2016) Selective novel inverse agonists for human GPR43 augment GLP-1 secretion. Eur. J. Pharmacol. 771, 1–9
32. Wang, Y., Jiao, X., Kayser, F., Liu, J., Wang, Z., Wanska, M., Greenberg, J., Weiszmann, J., Ge, H., Tian, H., Wong, S., Schwandner, R., Lee, T., and Li, Y. (2010) The first synthetic agonists of FFA2: discovery and SAR of phenylacetamides as allosteric modulators. Bioorg. Med. Chem. Lett. 20, 493–498
33. Leonard, J. N., Chu, Z. L., Bruce, M. A., Boatman, P. D. (2008) Gpr41 and modulators thereof for the treatment of insulin-related disorders. Patent US 20080312277 A1
34. Ang, Z., Er, J. Z., and Ding, J. L. (2015) The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes. Sci. Rep. 5, 8134
35. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
36. Pfaffl, M. W., Horgan, G. W., and Dempfle, L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36
37. Kodama, Y., and Hu, C.-D. (2010) An improved bimolecular fluorescence complementation assay with a high signal-to-noise ratio. Biotechniques 49, 793–805
38. Stoddart, L. A., Smith, N. J., Jenkins, L., Brown, A. J., and Milligan, G. (2008) Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids. J. Biol. Chem. 283, 32913–32924
39. Tian, L., Hires, S. A., Mao, T., Huber, D., Chiappe, M. E., Chalasani, S. H., Petreanu, L., Akerboom, J., McKinney, S. A., Schreiter, E. R., Bargmann, C. I., Jayaraman, V., Svoboda, K., and Looger, L. L. (2009) Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators. Nat. Methods 6, 875–881
40. Gouell, S., Hsaio, K. Monitoring the activity of G protein–coupled receptors (GPCR) modulated by lipid or free fatty acid agonists. (2009) Accessed August 30, 2017, at: https://www.promega.com/resources/pubhub/cellnotes/monitoring-the-activity-of-gpcrs–modulated-by-lipids-or-free-fatty-acids/
41. Kroeze, W. K., Sassano, M. F., Huang, X.-P., Lansu, K., McCorvy, J. D., Giguère, P. M., Sciaky, N., and Roth, B. L. (2015) PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362–369
42. Barnea, G., Strapps, W., Herrada, G., Berman, Y., Ong, J., Kloss, B., Axel, R., and Lee, K. J. (2008) The genetic design of signaling cascades to record receptor activation. Proc. Natl. Acad. Sci. USA 105, 64–69
43. Rico, A. J., Dopeso-Reyes, I. G., Martínez-Pinilla, E., Sucunza, D., Pignataro, D., Roda, E., Marín-Ramos, D., Labandeira-García, J. L., George, S. R., Franco, R., and Lanciego, J. L. (2017) Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation. Brain Struct. Funct. 222, 1767–1784
44. Karpova, T. S., Baumann, C. T., He, L., Wu, X., Grammer, A., Lipsky, P., Hager, G. L., and McNally, J. G (2003) Fluorescence resonance energy transfer from cyan to yellow fluorescent protein detected by acceptor photobleaching using confocal microscopy and a single laser. J. Microsc. 209, 56–70
45. Stoddart, L. A. (2007) Investigation of the Function, Pharmacology and Oligomerisation of GPR40, GPR41 and GPR43, University of Glasgow, Glasgow, United Kingdom
46. Joost, P., and Methner, A. (2002) Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol. 3, RESEARCH0063
47. Choi, R. C. Y., Simon, J., Tsim, K. W. K., and Barnard, E. A. (2008) Constitutive and agonist-induced dimerizations of the P2Y1 receptor: relationship to internalization and scaffolding. J. Biol. Chem. 283, 11050–11063
48. Jacobsen, S. E., Ammendrup-Johnsen, I., Jansen, A. M., Gether, U., Madsen, K. L., and Bräuner-Osborne, H. (2017) The GPRC6A receptor displays constitutive internalization and sorting to the slow recycling pathway. J. Biol. Chem. 292, 6910–6926
49. Levoye, A., Zwier, J. M., Jaracz-Ros, A., Klipfel, L., Cottet, M., Maurel, D., Bdioui, S., Balabanian, K., Prézeau, L., Trinquet, E., Durroux, T., and Bachelerie, F. (2015) A broad G protein–coupled receptor internalization assay that combines SNAP-tag labeling, diffusion-enhanced resonance energy transfer, and a highly emissive terbium cryptate. Front. Endocrinol. (Lausanne) 6, 167
50. Hudson, B. D., Christiansen, E., Tikhonova, I. G., Grundmann, M., Kostenis, E., Adams, D. R., Ulven, T., and Milligan, G. (2012) Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs. FASEB J. 26, 4951–4965
51. Lee, S. U., In, H. J., Kwon, M. S., Park, B. O., Jo, M., Kim, M.-O., Cho, S., Lee, S., Lee, H.-J., Kwak, Y. S., and Kim, S. (2013) b-Arrestin 2 mediates G protein–coupled receptor 43 signals to nuclear factor-kB. Biol. Pharm. Bull. 36, 1754–1759
52. Vinolo, M. A. R., Ferguson, G. J., Kulkarni, S., Damoulakis, G., Anderson, K., Bohlooly-Y, M., Stephens, L., Hawkins, P. T., and Curi, R. (2011) SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS One 6, e21205
53. Takasaki, J., Saito, T., Taniguchi, M., Kawasaki, T., Moritani, Y., Hayashi, K., and Kobori, M. (2004) A novel Galphaq/11-selective inhibitor. J. Biol. Chem. 279, 47438–47445
54. Herlaar, E., and Brown, Z. (1999) p38 MAPK signalling cascades in inflammatory disease. Mol. Med. Today 5, 439–447
55. Pin, J.-P., Neubig, R., Bouvier, M., Devi, L., Filizola, M., Javitch, J. A., Lohse, M. J., Milligan, G., Palczewski, K., Parmentier, M., and Spedding, M. (2007) International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein–coupled receptor heteromultimers. Pharmacol. Rev. 59, 5–13
56. Navarro, G., Cordomí, A., Zelman-Femiak, M., Brugarolas, M., Moreno, E., Aguinaga, D., Perez-Benito, L., Cortés, A., Casadó, V., Mallol, J., Canela, E. I., Lluís, C., Pardo, L., García-Sáez, A. J., McCormick, P. J., and Franco, R. (2016) Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs. BMC Biol. 14, 26
57. Gao, Z.-G., and Jacobson, K. A. (2016) On the selectivity of the Gaq inhibitor UBO-QIC: a comparison with the Gai inhibitor pertussis toxin. Biochem. Pharmacol. 107, 59–66
58. Hansen, A. H., Sergeev, E., Pandey, S. K., Hudson, B. D., Christiansen, E., Milligan, G., and Ulven, T. (2017) Development and characterization of a fluorescent tracer for the free fatty acid receptor 2 (FFA2/GPR43). J. Med. Chem. 60, 5638–5645